127 related articles for article (PubMed ID: 38876822)
1. MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome.
Dennys CN; Vermudez SAD; Deacon RJM; Sierra-Delgado JA; Rich K; Zhang X; Buch A; Weiss K; Moxley Y; Rajpal H; Espinoza FD; Powers S; Ávila AS; Gogliotti RG; Cogram P; Niswender CM; Meyer KC
Neurotherapeutics; 2024 Jun; ():e00376. PubMed ID: 38876822
[TBL] [Abstract][Full Text] [Related]
2. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.
Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD
J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Transcription Factor 4 in Pitt Hopkins Syndrome.
Rannals MD; Maher BJ
Curr Genet Med Rep; 2017 Mar; 5(1):1-7. PubMed ID: 30775158
[TBL] [Abstract][Full Text] [Related]
4. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
5. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of
Kim H; Gao EB; Draper A; Berens NC; Vihma H; Zhang X; Higashi-Howard A; Ritola KD; Simon JM; Kennedy AJ; Philpot BD
Elife; 2022 May; 11():. PubMed ID: 35535852
[TBL] [Abstract][Full Text] [Related]
6. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation episignature and comparative epigenomic profiling for Pitt-Hopkins syndrome caused by TCF4 variants.
van der Laan L; Lauffer P; Rooney K; Silva A; Haghshenas S; Relator R; Levy MA; Trajkova S; Huisman SA; Bijlsma EK; Kleefstra T; van Bon BW; Baysal Ö; Zweier C; Palomares-Bralo M; Fischer J; Szakszon K; Faivre L; Piton A; Mesman S; Hochstenbach R; Elting MW; van Hagen JM; Plomp AS; Mannens MMAM; Alders M; van Haelst MM; Ferrero GB; Brusco A; Henneman P; Sweetser DA; Sadikovic B; Vitobello A; Menke LA
HGG Adv; 2024 Apr; 5(3):100289. PubMed ID: 38571311
[TBL] [Abstract][Full Text] [Related]
8. A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
Aldeeri AA; Abu-El-Haija A
Am J Med Genet A; 2023 Apr; 191(4):1070-1076. PubMed ID: 36574749
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome.
Rannals MD; Page SC; Campbell MN; Gallo RA; Mayfield B; Maher BJ
Rare Dis; 2016; 4(1):e1220468. PubMed ID: 28032012
[TBL] [Abstract][Full Text] [Related]
10. Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na
Ekins S; Puhl AC; Davidow A
Pharm Res; 2020 Jun; 37(7):127. PubMed ID: 32529312
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
12. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
[TBL] [Abstract][Full Text] [Related]
14. Tcf4 dysfunction alters dorsal and ventral cortical neurogenesis in Pitt-Hopkins syndrome mouse model showing sexual dimorphism.
Espinoza F; Carrazana R; Retamal-Fredes E; Ávila D; Papes F; Muotri AR; Ávila A
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167178. PubMed ID: 38636614
[TBL] [Abstract][Full Text] [Related]
15. Pitt-Hopkins Syndrome.
Peippo M; Ignatius J
Mol Syndromol; 2012 Apr; 2(3-5):171-180. PubMed ID: 22670138
[TBL] [Abstract][Full Text] [Related]
16. WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene
Hennig KM; Fass DM; Zhao WN; Sheridan SD; Fu T; Erdin S; Stortchevoi A; Lucente D; Cody JD; Sweetser D; Gusella JF; Talkowski ME; Haggarty SJ
Mol Neuropsychiatry; 2017 Jul; 3(1):53-71. PubMed ID: 28879201
[TBL] [Abstract][Full Text] [Related]
17. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
[TBL] [Abstract][Full Text] [Related]
18. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum.
Whalen S; Héron D; Gaillon T; Moldovan O; Rossi M; Devillard F; Giuliano F; Soares G; Mathieu-Dramard M; Afenjar A; Charles P; Mignot C; Burglen L; Van Maldergem L; Piard J; Aftimos S; Mancini G; Dias P; Philip N; Goldenberg A; Le Merrer M; Rio M; Josifova D; Van Hagen JM; Lacombe D; Edery P; Dupuis-Girod S; Putoux A; Sanlaville D; Fischer R; Drévillon L; Briand-Suleau A; Metay C; Goossens M; Amiel J; Jacquette A; Giurgea I
Hum Mutat; 2012 Jan; 33(1):64-72. PubMed ID: 22045651
[TBL] [Abstract][Full Text] [Related]
19. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.
Sepp M; Pruunsild P; Timmusk T
Hum Mol Genet; 2012 Jul; 21(13):2873-88. PubMed ID: 22460224
[TBL] [Abstract][Full Text] [Related]
20. Pitt-Hopkins Mouse Model has Altered Particular Gastrointestinal Transits In Vivo.
Grubišić V; Kennedy AJ; Sweatt JD; Parpura V
Autism Res; 2015 Oct; 8(5):629-33. PubMed ID: 25728630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
